嚢胞性線維症児の難聴

A I Kryukov¹, A Yu Ivoilov¹, N A Mileshina²

¹Sverzhevsky Research Clinical Institute of Otorhinolaryngology, Moscow, Russia.

|March 1, 2026

Abstract:

The process of hearing impairment in children suffering from cystic fibrosis remains one of the pressing problems for the scientific medical community today. The article examines the effect of systemic antibacterial therapy with aminoglycoside antibiotics on the auditory function of children with cystic fibrosis.

Objective:

To analyze the causes of hearing loss and the causes of hearing impairment in children with cystic fibrosis from antibacterial therapy with aminoglycoside antibiotics.

Material And Methods:

Search for literature sources using the search engines PubMed, Web of Science and eLibrary.

Results:

A review of the literature shows that the acute problem of sensorineural hearing loss is associated with frequent use of aminoglycosides, and predictors of conductive hearing loss are inflammatory processes in the middle ear and eustachian tube. It has been demonstrated that not in all cases, antibacterial therapy with aminoglycoside antibiotics leads to hearing impairment, which demonstrates the urgent need to study the auditory function of children with cystic fibrosis and identify the characteristics of hearing impairment.

キーワード:

アミノグリコシド伝音難聴嚢胞性線維症小児難聴感音難聴

さらに関連する動画

06:04

Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages

Published on: March 24, 2023

902

09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

19.9K

関連する概念動画

01:23

Cystic Fibrosis: Pathogenesis

953

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

953

01:24

Cystic Fibrosis: Management

590

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

590